Processa Pharmaceuticals Inc
PCSA0.260USD
+0.034+15.50%
收盤 06/17, 16:00（美東）報價延遲15分鐘
1.37M總市值
虧損本益比TTM
關於 Processa Pharmaceuticals Inc 公司
Processa Pharmaceuticals, Inc. 是一家臨牀階段的生物製藥公司。該公司專注於利用其監管科學方法，包括與食品和藥物管理局 (FDA) 的 Project Optimus Oncology 計劃和相關的 FDA 指導草案相關的原則，開發下一代化療 (NGC) 腫瘤藥物產品。其正在研發的三種 NGC 治療藥物是 NGC-卡培他濱 (NGC-Cap)、PCS3117（也稱爲 NGC-吉西他濱 (NGC-Gem)）和 PCS11T（也稱爲 NGC-伊立替康 (NGC-Iri)）。NGC-Cap 是 PCS6422 和卡培他濱的組合，卡培他濱是抗癌藥物 5-氟尿嘧啶的口服前體藥物。 PCS3117 是吉西他濱的口服類似物，通過與吉西他濱不同的酶系統轉化爲其活性代謝物，導致吉西他濱患者和一些對吉西他濱治療有抵抗力的患者產生積極反應。PCS11T 是伊立替康 (SN-38) 活性代謝物的前體藥物。
公司簡介
公司代碼PCSA
公司名稱Processa Pharmaceuticals Inc
上市日期Oct 07, 2013
成立日期2011
CEOMr. George K. Ng
員工數量10
證券類型Ordinary Share
年結日Oct 07
公司地址7380 Coca Cola Dr Ste 106
城市HANOVER
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編21076-1789
電話14437763133
網址https://www.processapharmaceuticals.com/
公司代碼PCSA
上市日期Oct 07, 2013
成立日期2011
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. David Young, Ph.D.
Dr. David Young, Ph.D.
President - Research and Development, Director
President - Research and Development, Director
224.26K
-5.05%
Mr. George K. Ng
Mr. George K. Ng
Chief Executive Officer, Director
Chief Executive Officer, Director
150.80K
+40.67%
Mr. Patrick Lin
Mr. Patrick Lin
Chief Business and Strategy Officer
Chief Business and Strategy Officer
94.31K
+14.69%
Dr. Sian Bigora, Pharm.D.
Dr. Sian Bigora, Pharm.D.
Chief Development Officer and Regulatory Officer, Founder
Chief Development Officer and Regulatory Officer, Founder
21.88K
-34.94%
Ms. Wendy Guy
Ms. Wendy Guy
Founder, Chief Administrative Officer
Founder, Chief Administrative Officer
11.86K
-54.98%
Ms. Geraldine Pannu
Ms. Geraldine Pannu
Independent Director
Independent Director
2.88K
--
Mr. Khoso Baluch
Mr. Khoso Baluch
Independent Director
Independent Director
1.40K
--
Mr. Russell L. Skibsted
Mr. Russell L. Skibsted
Chief Financial Officer
Chief Financial Officer
--
--
Mr. James R. (Jim) Neal
Mr. James R. (Jim) Neal
Independent Director
Independent Director
--
--
Mr. Justin W. Yorke
Mr. Justin W. Yorke
Independent Chairman of the Board
Independent Chairman of the Board
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. David Young, Ph.D.
Dr. David Young, Ph.D.
President - Research and Development, Director
President - Research and Development, Director
224.26K
-5.05%
Mr. George K. Ng
Mr. George K. Ng
Chief Executive Officer, Director
Chief Executive Officer, Director
150.80K
+40.67%
Mr. Patrick Lin
Mr. Patrick Lin
Chief Business and Strategy Officer
Chief Business and Strategy Officer
94.31K
+14.69%
Dr. Sian Bigora, Pharm.D.
Dr. Sian Bigora, Pharm.D.
Chief Development Officer and Regulatory Officer, Founder
Chief Development Officer and Regulatory Officer, Founder
21.88K
-34.94%
Ms. Wendy Guy
Ms. Wendy Guy
Founder, Chief Administrative Officer
Founder, Chief Administrative Officer
11.86K
-54.98%
Ms. Geraldine Pannu
Ms. Geraldine Pannu
Independent Director
Independent Director
2.88K
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Young (David)
1.89%
Ng (George K)
1.27%
Lin (Patrick)
0.79%
Armistice Capital LLC
0.47%
Yorke (Justin W.)
0.45%
Other
95.13%
持股股東
持股股東
佔比
Young (David)
1.89%
Ng (George K)
1.27%
Lin (Patrick)
0.79%
Armistice Capital LLC
0.47%
Yorke (Justin W.)
0.45%
Other
95.13%
股東類型
持股股東
佔比
Individual Investor
4.78%
Investment Advisor/Hedge Fund
0.50%
Hedge Fund
0.49%
Research Firm
0.37%
Corporation
0.35%
Investment Advisor
0.08%
Other
93.43%
機構持股
更新時間: 3月4日 週二
更新時間: 3月4日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
50
637.00K
12.09%
+170.99K
2024Q4
53
384.33K
11.96%
-82.26K
2024Q3
54
333.95K
11.36%
-132.80K
2024Q2
56
390.99K
14.35%
-120.98K
2024Q1
59
435.26K
19.04%
+41.69K
2023Q4
57
343.21K
27.89%
+52.02K
2023Q3
57
335.15K
27.25%
+38.59K
2023Q2
52
272.47K
22.21%
-24.89K
2023Q1
53
282.76K
23.37%
-80.00
2022Q4
48
248.62K
31.29%
-31.42K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Young (David)
99.76K
1.89%
-1.00
-0.00%
Jan 24, 2025
Ng (George K)
20.00K
0.38%
--
--
Jan 24, 2025
Lin (Patrick)
29.06K
0.55%
+72.00
+0.25%
Jan 24, 2025
Yorke (Justin W.)
34.97K
0.66%
--
--
Jan 24, 2025
CorLyst, L.L.C.
41.46K
0.79%
-15.00K
-26.57%
Jan 24, 2025
Geode Capital Management, L.L.C.
21.98K
0.42%
+2.29K
+11.62%
Dec 31, 2024
The Vanguard Group, Inc.
24.43K
0.46%
--
--
Dec 31, 2024
Bigora (Sian)
21.88K
0.42%
--
--
Jan 24, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Jan 18, 2024
Merger
20<1
Jan 18, 2024
Merger
20<1
Jan 18, 2024
Merger
20<1
Jan 18, 2024
Merger
20<1
公告日期
類型
比率
Jan 18, 2024
Merger
20<1
Jan 18, 2024
Merger
20<1
Jan 18, 2024
Merger
20<1
Jan 18, 2024
Merger
20<1
